Eosinophil paradox with mepolizumab in chronic rhinosinusitis with nasal polyposis
- PMID: 32713686
- DOI: 10.1016/j.jaci.2020.05.054
Eosinophil paradox with mepolizumab in chronic rhinosinusitis with nasal polyposis
Comment in
-
Reply.J Allergy Clin Immunol. 2020 Sep;146(3):683-684. doi: 10.1016/j.jaci.2020.05.053. Epub 2020 Jul 24. J Allergy Clin Immunol. 2020. PMID: 32713687 No abstract available.
Comment on
-
Severe eosinophilic asthma with nasal polyposis: A phenotype for improved sinonasal and asthma outcomes with mepolizumab therapy.J Allergy Clin Immunol. 2020 Jun;145(6):1713-1715. doi: 10.1016/j.jaci.2020.02.002. Epub 2020 Feb 19. J Allergy Clin Immunol. 2020. PMID: 32084443 Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
